The proposed rule would permanently exclude semaglutide, tirzepatide, and liraglutide from the 503B bulks list, meaning that even a future shortage would not reopen large-scale compounding through outsourcing facilities
Feleppa M
Potential Risk of Pancreatitis: Like other GLP-1 receptor agonists, Retatrutide may increase the risk of pancreatitis, although this risk is considered relatively low
The adverse effect profiles summarized above for liraglutide, semaglutide, and tirzepatide are derived entirely from studies in common obesity and type 2 diabetes
These include vitamins C and E, glutathione, coenzyme Q10, selenium, and zinc
Longnus SL, Wambolt RB, Barr RL, Lopaschuk GD, Allard MF (octubre de 2001)